CA2680771A1 — Use of 1-phenyl-3-dimethylaminopropane compounds for treating neuropathy pain
Assigned to Gruenenthal GmbH · Expires 2008-09-18 · 18y expired
What this patent protects
The invention relates to the use of 1-phenyl-3-dimethylamino-propane comp ounds for the production of pharmaceuticals for the treatment of neuropathic , preferably of polyneuropathic pain, further preferably of diabetic neuropa thic pain, preferably diabetic peripheral neuropathi…
USPTO Abstract
The invention relates to the use of 1-phenyl-3-dimethylamino-propane comp ounds for the production of pharmaceuticals for the treatment of neuropathic , preferably of polyneuropathic pain, further preferably of diabetic neuropa thic pain, preferably diabetic peripheral neuropathic pain, further preferab ly for the treatment of diabetic peripheral neuropathy.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.